Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:ALXN
Delisted

Alexion Pharmaceuticals Stock Price (Quote)

$182.50
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $6.10 $80.02 Friday, 27th May 2022 ALXN stock ended at $182.50. During the day the stock fluctuated 0% from a day low at $182.50 to a day high of $182.50.
90 days $71.43 $25.28
52 weeks $0.340 $25.28

Historical Alexion Pharmaceuticals prices

Date Open High Low Close Volume
Aug 25, 2016 $129.17 $129.17 $129.17 $129.17 1 695 200
Aug 24, 2016 $132.12 $132.12 $132.12 $132.12 1 395 700
Aug 23, 2016 $137.42 $137.42 $137.42 $137.42 903 100
Aug 22, 2016 $136.53 $136.53 $136.53 $136.53 1 321 100
Aug 19, 2016 $132.14 $132.14 $132.14 $132.14 795 200
Aug 18, 2016 $132.43 $132.43 $132.43 $132.43 1 024 000
Aug 17, 2016 $133.06 $133.06 $133.06 $133.06 1 004 900
Aug 16, 2016 $133.76 $133.76 $133.76 $133.76 666 200
Aug 15, 2016 $136.07 $136.07 $136.07 $136.07 1 192 700
Aug 12, 2016 $133.44 $133.44 $133.44 $133.44 1 096 200
Aug 11, 2016 $133.67 $133.67 $133.67 $133.67 701 300
Aug 10, 2016 $132.67 $132.67 $132.67 $132.67 1 586 400
Aug 09, 2016 $135.00 $135.00 $135.00 $135.00 858 000
Aug 08, 2016 $136.08 $136.08 $136.08 $136.08 1 171 500
Aug 05, 2016 $137.11 $137.11 $137.11 $137.11 1 470 100
Aug 04, 2016 $135.43 $135.43 $135.43 $135.43 1 708 000
Aug 03, 2016 $137.66 $137.66 $137.66 $137.66 2 084 100
Aug 02, 2016 $133.61 $133.61 $133.61 $133.61 2 285 600
Aug 01, 2016 $133.50 $133.50 $133.50 $133.50 3 425 400
Jul 29, 2016 $128.60 $128.60 $128.60 $128.60 1 895 500
Jul 28, 2016 $130.40 $130.40 $130.40 $130.40 2 899 300
Jul 27, 2016 $129.78 $129.78 $129.78 $129.78 2 110 700
Jul 26, 2016 $126.65 $126.65 $126.65 $126.65 1 331 600
Jul 25, 2016 $127.46 $127.46 $127.46 $127.46 1 382 200
Jul 22, 2016 $125.80 $125.80 $125.80 $125.80 1 381 800
Click to get the best stock tips daily for free!

About Alexion Pharmaceuticals

Alexion Pharmaceuticals Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The company offers Soliris (eculizumab), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a genetic blood disorder; and atypical hemolytic uremic syndrome (aHUS), a genetic disease. It provides Strensiq (asfotase alfa), a targeted enzyme replacement therapy for patients with hypophosp... ALXN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT